Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain

Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain

Abstract Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess disease characteristics and icatibant treatment ou...

Full description

Bibliographic Details
Main Authors: Mar Guilarte, Anna Sala-Cunill, María Luisa Baeza, Rosario Cabañas, María Dolores Hernández, Ethel Ibañez, Carlos Hernando de Larramendi, Ramon Lleonart, Teófilo Lobera, Luis Marqués, Blanca Sáenz de San Pedro, Jaco Botha, Irmgard Andresen, Teresa Caballero, for the IOS Study Group
Format: Article
Language:English
Published: BMC 2021-12-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Hereditary angioedema
Registries
Spain
Bradykinin
Bradykinin B2 receptor antagonists
Icatibant
Online Access:https://doi.org/10.1186/s13223-021-00641-3

Internet

https://doi.org/10.1186/s13223-021-00641-3

Similar Items